Regeneron Pharmaceuticals Inc

NAS:REGNHealthcareCBOE:SPESGNASDAQ:NBI

$782.04−1.10%At closeAt close · Tue 20 Oct · ≈ AED 2,872.04 · Market cap $80.51B · Next earnings Wed 28 Oct · Extended $785.00 +0.38%

Beat (%) vs consensus · next report Wed 28 Oct

DateWed, 28 Oct 2026

EPS estimate16.00

Revenue estimate4,542.3m

Currency—

Report	EPS estimate	EPS actual	EPS surprise	Revenue estimate (m)	Revenue actual (m)	Revenue surprise
2026-07-30	10.16	12.23	+20.4%	3,817.3	4,290.7	+12.4%
2026-04-29	8.91	9.47	+6.3%	3,480.5	3,605.4	+3.6%
2026-01-30	10.74	11.44	+6.5%	3,810.7	3,884.3	+1.9%
2025-10-28	9.65	11.83	+22.6%	3,592.2	3,754.3	+4.5%
2025-08-01	8.43	12.89	+52.9%	3,288.1	3,675.6	+11.8%
2025-04-29	8.62	8.22	−4.6%	3,248.0	3,028.7	−6.8%
2025-02-04	11.21	12.07	+7.7%	3,742.2	3,789.2	+1.3%
2024-10-31	11.69	12.46	+6.6%	3,674.8	3,720.7	+1.2%
2024-08-01	10.61	11.56	+9.0%	3,383.5	3,547.1	+4.8%
2024-05-02	10.17	9.55	−6.1%	3,225.2	3,145.0	−2.5%
2024-02-02	10.73	11.86	+10.5%	3,294.4	3,434.3	+4.2%
2023-11-02	10.72	11.59	+8.1%	3,221.0	3,362.7	+4.4%

Currency not supplied by the earnings feedUpdated Thu 30 Jul ·

ⓘ

Surprise is actual minus consensus, as a share of the consensus.